For most of sports history, a head injury was something that happened on a Tuesday and was forgotten by Saturday. A player took a blow, sat briefly on the sideline, perhaps complained of a headache, and returned to training. The language around it was casual: “getting your bell rung,” “seeing stars,” “taking a knock.” The implicit message was clear – it was temporary, unremarkable, and the appropriate response was to get back out there.
That understanding is now entirely overturned.
Over the past two decades, a body of scientific research – built from donated brains, advanced neuroimaging, longitudinal cohort studies, and blood biomarker analysis – has established something that is no longer seriously disputed in the medical and neuroscientific community: repetitive head impacts, blows and jolts, a repeated head trauma that may or may not result in clinically identified injury, are a growing public health concern due to their links with neurodegenerative disease and long-term dysfunction.
This post is a comprehensive overview of what science now understands about the long-term consequences of repetitive head trauma: what conditions it causes, how the damage progresses, who is most at risk, what is being done to detect it in living people, and what this means for every athlete, coach, and parent involved in contact sport today.
The central finding: it is not just the concussions that matter
The most important conceptual shift in brain injury science over the last decade is this: the long-term risk of brain disease in contact sport athletes is driven primarily not by the individual diagnosed concussions, but by the accumulated burden of sub-concussive impacts – the hundreds or thousands of head acceleration events across a career that individually produce no symptom, generate no medical response, and leave no entry in any injury record.
While these impacts may be symptomatic or asymptomatic in the short term, long-term exposure can lead to severe neurological outcomes, including chronic traumatic encephalopathy (CTE), a degenerative brain disease with varied clinical and neuropathological features.
It is believed that repetitive brain trauma, with or possibly without symptomatic concussion, is responsible for neurodegenerative changes highlighted by accumulations of hyperphosphorylated tau and TDP-43 proteins.
The athlete who gets through an entire season without a single concussion diagnosis is not necessarily the player whose brain has been unaffected by the season. The damage is accumulating regardless – silently, incrementally, and as the science now clearly shows, measurably.
What is CTE?
Chronic Traumatic Encephalopathy – CTE – is a progressive neurodegenerative disease uniquely associated with a history of repetitive head trauma. It was first described in the 1920s in boxers, where it was called “dementia pugilistica” or “punch drunk syndrome.” Over the following century, it has been identified in athletes across American football, ice hockey, rugby, football/soccer, wrestling, and other contact sports, as well as in military veterans exposed to repeated blast injuries.
CTE results in a progressive decline of memory and cognition, as well as depression, suicidal behaviour, poor impulse control, aggressiveness, parkinsonism, and, eventually, dementia. In some individuals, it is associated with motor neuron disease, referred to as chronic traumatic encephalomyelopathy, which appears clinically similar to amyotrophic lateral sclerosis.
The four stages of CTE pathology
Neuropathologists have characterised the progression of CTE in four stages based on the extent and location of tau protein accumulation in the brain:
Stage 1: Mild, with localised tau pathology around small blood vessels. Stage 2: Moderate tau pathology with visible brain atrophy. Stage 3: Significant neurofibrillary tangles and brain atrophy affecting memory, emotion, and motor function. Stage 4: Severe atrophy, widespread neurofibrillary tangles, and significant functional impairment.
Critically, the early stages of CTE pathology may be present in the brain years or decades before any clinical symptoms appear – meaning the disease process begins long before anyone notices anything is wrong.
The tau protein – what is actually happening in the brain
Tau protein in CTE has a characteristic hyperphosphorylated form and initially deposits in a distinctive perivascular pattern at the depths of cortical sulci. In a healthy brain, tau proteins help stabilise the internal transport network of neurons – the cellular highways that carry nutrients and signals within brain cells. In CTE, these proteins detach from the transport network, misfold, and aggregate into tangles that disrupt cellular function, cause synapse loss, and ultimately lead to neuronal death.
The aggregation of tau in neurofibrillary tangles induces several neurotoxic mechanisms, including microtubule destabilisation, synapse loss, and potential aberrations of intracellular signalling, causing neuronal death. This leads to macro-scale changes, such as brain atrophy.
What makes CTE’s tau pattern distinctive – and diagnosable separately from Alzheimer’s disease – is its perivascular localisation at the sulcal depths of the cortex. The deposition of an abnormal tau protein that clusters around blood vessels in the brain is a very distinct and specific lesion for CTE. There is no other disease that causes those changes in tau protein – and that is how a distinctive diagnosis is made.
How common is CTE?
The honest answer is that the true population prevalence of CTE is unknown, because the only definitive diagnosis currently possible is post-mortem examination of brain tissue. The figures that exist come from brain bank studies, which are subject to significant selection bias – families whose relatives showed symptoms are more likely to donate brains for research, meaning the diagnosed rates in these studies are not representative of all contact sport athletes.
With that important caveat, the numbers from controlled studies are striking.
A 2025 systematic review and meta-analysis published in the Scandinavian Journal of Medicine & Science in Sports, examining eight eligible studies involving 1,000 former contact sport athletes diagnosed by neuropathological methods, found that the pooled prevalence of CTE in contact sport athletes was 53.7%.
The sport-specific figures from the Boston University CTE Centre’s brain bank studies are even more arresting at the elite level. Among donated brains from NFL players, the rate of CTE diagnosis has been reported at 99%. Among former NHL ice hockey players in the December 2024 JAMA Network Open study, 96% of professional players examined had CTE. Among former professional footballers (soccer) whose brains have been examined post-mortem, CTE has been identified in multiple studies alongside markedly elevated rates of Alzheimer’s disease and other neurodegenerative conditions.
Again – selection bias means these figures cannot be read as prevalence estimates for all athletes. But they are the most rigorous data available, and the consistency of the finding across sports, institutions, and methodologies is scientifically significant.
Beyond CTE: the full spectrum of long-term consequences
CTE is the condition that has received the most attention, but it is not the only long-term consequence of repetitive head trauma. The full spectrum of conditions associated with a history of repeated head impacts is broader, and in many ways more immediately relevant to athletes who are currently competing.
Alzheimer’s disease and other dementias
A history of repeated head trauma is associated with significantly elevated risk of Alzheimer’s disease and other forms of dementia. Secondary injury, such as inflammation, oxidative stress, and excitotoxicity, are central drivers of neurodegeneration and may lead to chronic traumatic encephalopathy, Alzheimer’s disease, and other neurodegenerative disorders.
The large-scale study of former professional footballers (soccer) published in 2019 found they were 3.5 times more likely to die from dementia or other neurodegenerative diseases than age-matched controls from the general population. The elevated risk was not confined to players who had diagnosed concussions – it was observed across the cohort, pointing to the cumulative sub-concussive load of heading and contact over a career as the likely driver.
Parkinson’s disease and movement disorders
The link between repetitive head trauma and Parkinson’s disease – or parkinsonism, an umbrella term covering Parkinson’s-like movement disorders – has been established in multiple sports and populations. A 2024 study found a new link between playing contact sports, CTE, and the development of a movement disorder. Playing tackle football may increase the risk for Parkinson’s disease, with a study from August 2023 identifying history of contact sport participation as a risk factor for Parkinson’s diagnosis.
The mechanism involves the disruption of dopaminergic pathways – the same neural circuits affected in idiopathic Parkinson’s disease – through the progressive neurodegeneration associated with CTE pathology and tau accumulation.
ALS and motor neuron disease
In some individuals, CTE is associated with motor neuron disease, referred to as chronic traumatic encephalomyelopathy, which appears clinically similar to amyotrophic lateral sclerosis. Research on both American football players and military veterans has found elevated rates of ALS diagnosis compared with the general population. The pathway from repetitive head trauma to motor neuron disease is not fully understood, but the association is consistent across multiple independent studies.
White matter damage and cognitive decline
Even in athletes who are currently active and have no CTE diagnosis, imaging studies consistently find evidence of structural brain changes associated with a season of contact sport. Lifetime head trauma exposure is associated with degenerative neuroimaging biomarkers, and greater frequency and severity of head trauma are associated with more pronounced degenerative neuroimaging findings.
The specific finding that has emerged most consistently is damage to white matter – the network of insulated axonal connections that carries signals between different brain regions. Growing evidence underscores the cumulative damage caused by repeated mild TBI, highlighting the urgent need for greater awareness and targeted research to address its long-term consequences. White matter damage impairs information processing speed, working memory, executive function, and attention – the cognitive capacities that athletes and non-athletes alike depend on throughout their lives.
Mental health: depression, anxiety, and suicide
The relationship between repetitive head trauma and mental health outcomes is one of the most important and least discussed dimensions of the long-term risk profile.
A 2024 study found that former amateur contact sport athletes exhibited a 2.25-fold higher likelihood of being diagnosed with mental health disorders and a 1.29-fold higher likelihood of using associated medications compared to non-contact athletes. The finding that this elevated risk extends to amateur athletes – not just professionals – is significant for the scale of the public health concern.
Many people who sustain a traumatic brain injury report difficulties with anxiety, depression, and substance misuse as they are recovering. Some report thoughts about ending their lives or suicide attempts.
While some studies show that as few as three or more concussions may increase the risk of depression or anxiety later in life, mental health outcomes vary widely. Not every athlete with a history of concussion will experience these issues, but the risks are real, and they highlight the importance of prevention, education, and careful monitoring.
The connection between CTE and suicide specifically has become one of the most urgent areas of research. Several high-profile cases of former professional athletes – whose brains were subsequently found to have CTE – died by suicide. Research emphasises suicide as a potential outcome of CTE in former contact sport athletes, and further studies should incorporate more female athletes to comprehensively assess the risk factors and outcomes.
It is critical to note that the vast majority of people with a history of head trauma do not die by suicide, and that the relationship between brain injury and suicidality is complex, multifactorial, and not fully understood. The presence of CTE pathology appears to significantly elevate risk in some individuals through the behavioural and emotional dysregulation that characterises the disease – but it is not a deterministic outcome.
Risk factors: who is most vulnerable?
Not every athlete with a history of repetitive head impacts develops CTE or other neurodegenerative disease. Several factors appear to modulate individual vulnerability.
Years and volume of exposure
The single strongest predictor of long-term risk identified across the research is the total cumulative exposure to head impacts – measured most simply as years of participation in contact sport. The Boston University research found that CTE risk in American football players doubles approximately every 2.6 years of continued contact play. The December 2024 JAMA ice hockey study found that CTE odds increased by 34% for each additional year of play. The dose-response relationship is among the most consistent findings in the literature.
Age of first exposure
Multiple lines of evidence suggest that beginning contact sport before the age of 12 is associated with worse long-term outcomes. The developing brain is more vulnerable to the effects of repeated rotational forces, and early exposure extends the total duration of lifetime cumulative exposure. Age of first exposure to tackle football and years played are associated with less white matter in the brain.
Sex differences
Female athletes appear to be at elevated concussion risk in comparable sports – in sports where both boys and girls compete separately, girls are 12% more likely to suffer a concussion than boys. The research on long-term outcomes in female athletes is substantially less developed than in males, reflecting historical underrepresentation of women in sports neuroscience research. This is an urgent gap that the scientific community is beginning to address.
Genetic factors
Various factors such as duration of sports involvement and genetic predispositions impact the severity of tau pathology associated with CTE. Transmembrane Protein 106B (TMEM106B) is a key gene linked to CTE and is one of the first genetic factors identified. The gene burden can help explain why some athletes show severe CTE symptoms while others have milder effects despite similar head trauma levels.
The APOE4 allele – the same genetic variant associated with elevated Alzheimer’s risk – has also been studied as a potential modifying factor in CTE, though findings are not yet conclusive.
Number and severity of diagnosed concussions
While the research increasingly emphasises sub-concussive exposure as the primary driver of long-term risk, diagnosed concussions remain relevant. Multiple concussions are associated with worse long-term outcomes across cognitive, emotional, and neuroimaging measures. Retrospective reports have linked CTE pathology to a history of repetitive head impacts, as well as a constellation of clinical symptoms, including cognitive decline, neuropsychiatric disturbances, motor dysfunction, and functional impairment.
Can CTE be diagnosed in a living person?
This is one of the most important questions in sports medicine today – and the honest answer is: not yet, with certainty. Currently, CTE cannot be diagnosed in living individuals and can only be identified post-mortem through brain tissue analysis.
This is both a scientific limitation and a profound clinical challenge. It means that an athlete who is worried about their brain health cannot receive a definitive diagnosis, and that the research community cannot yet conduct the large-scale prospective studies that would establish definitively how many living athletes are affected.
However, the search for in-vivo biomarkers is one of the most active areas of sports neuroscience, and progress is real.
Tau PET imaging
Researchers are using tau PET scans to measure the levels of tau tangles in the brain to understand how they drive cognitive decline. The scan has detected greater amounts of abnormal tau protein build-up in the group of living NFL players compared to a control group – but limitations mean it cannot yet be used for individual diagnosis. The study analysed grouped data and not individual findings.
Blood biomarkers
Glial fibrillary acidic protein (GFAP), a marker of astrocytic injury and degeneration, is elevated in patients exposed to repetitive head injury, predicting progressive regional atrophy and cognitive decline. Neurofilament light protein (NfL), total tau, and various phosphorylated tau isoforms are all under active investigation as potential blood-based biomarkers of CTE and traumatic encephalopathy syndrome (TES).
Current research analysing cerebrospinal fluid in living football players is further elucidating differences in tau characteristics. The field is moving rapidly, driven by the urgent clinical need and by the methodological progress being made in Alzheimer’s disease biomarker research, which shares many of the same molecular targets.
MRI structural changes
Former fighters with traumatic encephalopathy syndrome have evident volume loss in the mamillary bodies, fornix, and other Papez circuit structures, compared with those without the syndrome and with controls. A prominent cavum septum pellucidum – a structural feature observable on standard MRI – is more common in former American football players and combat sport athletes than in the general population, and may represent a marker of cumulative head trauma exposure.
The most likely near-term scenario is that diagnosis will become possible through a combination of biomarkers – blood protein analysis, imaging, cognitive assessment, and clinical history – rather than through any single definitive test. A call to find and validate diagnostic biomarkers for CTE is now being made by leading researchers, acknowledging that insights are coming from ongoing longitudinal cohort studies.
The clinical picture: what does life with CTE look like?
The clinical presentations of CTE vary considerably between individuals and across the stages of disease progression. Two broad clinical subtypes have been identified in the literature.
The first is characterised primarily by behavioural and mood changes – appearing earlier in life, often in the 30s and 40s in former athletes. Explosivity, poor impulse control, depression, and hopelessness are the defining features. This subtype has been associated with a higher risk of suicidal behaviour.
The second subtype is characterised more by cognitive decline – impaired memory, executive function, attention, and eventually dementia – typically appearing later, in the 60s and 70s. This presentation overlaps significantly with Alzheimer’s disease, which is one of the reasons that distinguishing between the two conditions – and understanding how they interact – is a major research priority.
In reality, many individuals show features of both subtypes, and the disease in its more advanced stages becomes increasingly difficult to distinguish from other forms of dementia on clinical grounds alone.
The long-term consequences of repetitive head impacts have been described since the early 20th century. A more generic designation, chronic traumatic encephalopathy, has been employed since the mid-1900s to describe a neurodegenerative disease found not just in boxers but in American football players, other contact sport athletes, military veterans, and others with histories of repetitive brain trauma, including concussions and subconcussive trauma. The clinical features include impairments in mood such as depression and hopelessness, behaviour such as explosivity and violence, cognition such as impaired memory, executive functioning, attention, and dementia, and, less commonly, motor dysfunction.
What can be done – today, practically, at every level
The picture that this science paints is serious. It is also not a reason for despair, because the evidence on prevention is equally clear: the single most powerful modifiable risk factor for long-term brain disease in contact sport athletes is the total cumulative exposure to head impacts across a career. And cumulative exposure can be managed.
Start later, risk less
The evidence on age of first exposure is among the strongest in the field. Delaying the start of full-contact sport participation – particularly tackle football, and contact-heavy training in ice hockey, rugby, and other collision sports – until the brain is more fully developed reduces the total lifetime duration of exposure and protects the brain during its most vulnerable developmental period. This is not about removing children from sport; it is about sequencing contact introduction intelligently.
Reduce sub-concussive load in training
Practice and training sessions represent the single most controllable source of cumulative sub-concussive exposure. Limiting full-contact repetitions, replacing some contact drills with technical alternatives, and reducing high-frequency heading and checking repetitions in training all have a meaningful effect on cumulative brain load across a season – without significantly compromising athletic development.
Never minimise a concussion
Every diagnosed concussion should be taken seriously, managed conservatively, and cleared only when the athlete has completed a graduated return-to-play protocol under appropriate medical supervision. Same-day return to play is never safe. The evidence that multiple concussions compound long-term risk is consistent and unambiguous.
Measure the sub-concussive load
Here is the hardest and most important practical point: the exposure that drives the greatest long-term risk is the exposure that produces no symptom and triggers no clinical response. It is invisible to standard injury surveillance. It accumulates regardless of whether anyone is counting.
The only way to make it visible is to measure it. A head impact sensor worn during training and competition records the number, magnitude, frequency, and proximity of every significant head acceleration event – building a cumulative picture of brain load across a session, a season, and a career. This data does not diagnose injury. It does not replace medical judgement. But it provides coaches, physiotherapists, and athletes with information that would otherwise simply not exist – information that enables genuinely proactive decisions about load management rather than reactive responses to symptoms that may not appear for years.
Seek appropriate mental health support
Given the association between repetitive head trauma and elevated rates of depression, anxiety, and other mental health conditions, athletes with a significant history of head impacts should not hesitate to seek mental health support. The stigma that has historically surrounded mental health in sport is incompatible with what the science now shows: that brain injury can directly alter mood, behaviour, and emotional regulation through neurobiological mechanisms that are not a matter of personal weakness or choice.
The bigger picture
The long-term effects of repetitive head trauma represent one of the most important public health questions in contemporary sport. The science has moved decisively and consistently in one direction over the past two decades. Repetitive head impacts are a growing public health concern due to links with neurodegenerative disease and long-term dysfunction. Establishing causal links between repetitive head impacts and clinical outcomes remains challenging due to methodological constraints, but the associations are consistent across populations, sports, and methodologies.
We are not yet at the point where a living athlete can receive a definitive CTE diagnosis, or where a blood test can tell a former player whether they are on a path toward dementia. But we are at the point where the risk factors are clearly identified, where the mechanisms are well understood, and where the practical tools for managing exposure are available.
The response to this science has to be proportionate: better education, better rules, better protocols, and better data. Not to end contact sport – but to ensure that every athlete who plays contact sport does so with the best possible protection for the brain they will depend on long after their playing days are over.
There is no medication. No cure. Prevention – informed, consistent, data-driven, and beginning from the earliest years of participation – is the only path forward. And it is a path that can genuinely make a difference.
If you or someone you know is experiencing mental health difficulties, please seek support from a qualified mental health professional or contact your national crisis line.
ACT Head Impact Tracker is a measurement device. ACT Head Impact Tracker is not a medical device. It does not provide medical advice, diagnostics, or treatment suggestions. In case of suspected head injury, immediately and safely remove the athlete from activity and seek assessment from a licensed medical professional.
For more information, or to buy your sensor, visit